News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,649 Results
Type
Article (13691)
Company Profile (108)
Press Release (249850)
Section
Business (88235)
Career Advice (471)
Deals (15356)
Drug Delivery (64)
Drug Development (36632)
Employer Resources (49)
FDA (6287)
Job Trends (6208)
News (150485)
Policy (14050)
Tag
Academia (447)
Alliances (23234)
Alzheimer's disease (370)
Approvals (6299)
Artificial intelligence (72)
Bankruptcy (144)
Best Places to Work (4372)
Breast cancer (65)
Cancer (451)
Cardiovascular disease (47)
Career advice (412)
Cell therapy (62)
Clinical research (30673)
Collaboration (231)
Compensation (96)
COVID-19 (753)
C-suite (76)
Data (448)
Diabetes (64)
Diagnostics (1251)
Drug discovery (45)
Drug pricing (59)
Earnings (31706)
Events (37142)
Executive appointments (257)
FDA (6554)
Funding (152)
Gene therapy (73)
GLP-1 (315)
Government (1275)
Healthcare (3601)
Infectious disease (775)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5856)
Job creations (2055)
Job search strategy (378)
Layoffs (170)
Legal (3424)
Lung cancer (64)
Manufacturing (113)
Medical device (1288)
Medtech (1290)
Mergers & acquisitions (9600)
Metabolic disorders (201)
Neuroscience (494)
NextGen: Class of 2025 (1594)
Non-profit (603)
Northern California (549)
Obesity (120)
Opinion (113)
Patents (70)
People (28720)
Pharmaceutical (67)
Phase I (7999)
Phase II (12972)
Phase III (11642)
Pipeline (231)
Policy (47)
Postmarket research (1401)
Preclinical (3193)
Radiopharmaceuticals (117)
Rare diseases (115)
Real estate (2649)
Regulatory (9955)
Research institute (566)
Resumes & cover letters (56)
Southern California (532)
Startups (1629)
United States (5326)
Vaccines (122)
Weight loss (87)
Date
Today (20)
Last 7 days (141)
Last 30 days (690)
Last 365 days (12401)
2025 (596)
2024 (12570)
2023 (14315)
2022 (19645)
2021 (20166)
2020 (19117)
2019 (14970)
2018 (11776)
2017 (13934)
2016 (13161)
2015 (15529)
2014 (12454)
2013 (10618)
2012 (11432)
2011 (11949)
2010 (10907)
Location
Africa (314)
Arizona (45)
Asia (19986)
Australia (2576)
California (1280)
Canada (717)
China (169)
Colorado (51)
Connecticut (54)
Europe (39145)
Florida (209)
Illinois (145)
Indiana (103)
Japan (59)
Kansas (53)
Maryland (186)
Massachusetts (1107)
Minnesota (70)
New Jersey (529)
New York (357)
North Carolina (315)
Northern California (549)
Pennsylvania (337)
South America (511)
Southern California (532)
Texas (168)
Virginia (49)
Washington State (85)
263,649 Results for "hec pharmaceutical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology
December 12, 2024
·
5 min read
Biotech Beach
ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC)
ChromaDex Corp., the global authority on nicotinamide adenine dinucleotide research and its application to healthy aging, unveils Niagen+, the first-of-its-kind pharmaceutical-grade Niagen®.
June 13, 2024
·
9 min read
Pharm Country
HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity
ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, announced it will design, manufacture, and install multiple 4,000L fermenter trains for HEC Pharm’s manufacturing site in Guangzhou, China.
April 12, 2021
·
2 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Business
SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth
SERB Pharmaceuticals has appointed Vanessa Wolfeler as its new Chief Executive Officer (CEO) effective 3 June 2024.
May 30, 2024
·
2 min read
Press Releases
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
January 14, 2025
·
6 min read
Press Releases
Olympia Pharmaceuticals Announces the Launch of Sister Brand, Wesley Pharmaceuticals, in Honor of Beloved Employee
December 18, 2024
·
3 min read
Press Releases
Apollo Therapeutics Signs Exclusive Ex-China License From Sunshine Lake Pharma for Clinical-Stage FGF21 / GLP-1 Dual Receptor Agonist, a Therapeutic With Major Commercial Potential in Multiple Indications
November 12, 2024
·
6 min read
Press Releases
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
November 27, 2024
·
1 min read
Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting
Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from ongoing preclinical research on the topical administration of a formulation of Provectus’s proprietary, pharmaceutical-grade, small molecule, rose bengal sodium (“RBS”) drug substance are being presented at the annual meeting of the Society for Investigative Dermatology (“SID”), to be held May 15-18, 2024 in Dallas, Texas.
February 29, 2024
·
3 min read
1 of 26,365
Next
